Quotient Limited (“Quotient”) (NASDAQ: QTNT), an established, commercial-stage diagnostics company, today announced the recent FDA approval for U.S. commercialisation of seven new blood bank reagents including two market firsts. The new products are: Monoclonal Antisera ALBAclone® Anti-Fy[b] ALBAclone® Anti-C[w] ALBAclone® Anti-e ALBAclone® Anti-C Anti-Human Globulin (AHG): Anti-IgG Anti-IgG,-C3d; Polyspecific Anti-C3d “We are very proud to be first to market with FDA approved monoclonal Anti-Fy[b] and monoclonal...
It’s widely held that artificial intelligence (AI) will soon come to revolutionise every part of our lives, but nowhere more so than in healthcare – and that’s an area of innovation where Scotland is firmly leading the way. I recently attended the Edinburgh International Science Festival where AI was a hot topic of discussion. There was one recurrent question: how can Scotland further excel in...
Vascutek and Bolton Medical, subsidiaries of Terumo Corporation of Japan, have combined into Terumo Aortic. Combining the aortic companies into a single business, Terumo looks to grow its presence in the global aortic and vascular implants market. The new company brings together two leaders in the aortic implant market. The new identity underlines Terumo’s global growth ambitions, further to a previous US$43 million factory investment. Known as...
Transfusion diagnostics company, Quotient, has official opened its state-of-the-art Allan-Robb Campus within the Scottish Enterprise Biocampus just outside of Edinburgh. Paul Cowan, Founder of Quotient, said, “The inauguration of the Allan-Robb Campus testifies to Quotient’s long-term commitment to the global transfusion diagnostics market, both through the on-going supply of liquid reagents and through its transformational MosaiQ™ transfusion diagnostics system that provides a comprehensive automated testing solution,...
A new method of using light to scan the human body, developed by researchers at the University of St Andrews, could result in less intrusive and more effective diagnosis for patients. The work is the result of a collaboration between researchers from the Schools of Physics and Astronomy, Biology, Medicine and the Scottish Oceans Institute at the University. The new technique allows the light to...
A new way to rapidly assess levels of consciousness in people with head injuries could improve patient care. The new score – based on the Glasgow Coma Scale – could also help doctors assess the health of the patient’s central nervous system in cases of serious trauma or intensive care. The Glasgow Coma Scale (GCS) was created at the University of Glasgow and the city’s...